Abbott statement on cyber incident in Cancer Diagnostics business
July 16, 2026
- Copy Link
- Share on X
- Share on Facebook
- Share on Linkedin
Abbott is investigating a cyber incident in which there was unauthorized access to a limited number of internal systems in our Cancer Diagnostics business only. This does not impact any business operations, product or product availability, manufacturing or lab operations, or our ability to serve patients.
There is no impact to any other Abbott businesses, sites or systems. The legacy Exact Sciences systems are separate from Abbott’s.
Upon learning this, we took immediate steps to address the situation. We have engaged leading third-party cybersecurity experts and law enforcement and are working diligently to further investigate the information accessed and resolve this issue.
Based on what we know at this time, we do not expect any material impact on the business or financial results. We take our responsibility to protect our systems and data very seriously and will continue to closely monitor our systems.
For the latest on Abbott’s life-changing technology, get updates directly in your inbox.